Protective effects of dibutyryl cyclic AMP on acute hepatic failure in rats

Journal of Surgical Research

Volumn 66, Issue 1, 1996, Pages 75-80

  Kasai, Shinichi ^a   Kakisaka, Akitoshi ^a   Kudo, Koichi ^a   Mito, Michio ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; ENDOTOXIN; GALACTOSAMINE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; HISTOLOGY; LIVER FAILURE; LIVER PROTECTION; MACROPHAGE ACTIVATION; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE BLOOD FLOW;

EID: 0030293831     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0375     Document Type: Article

References (27)

1. 1. Okita, K., Matsuda, S., Hata, K., et al. Clinical use of glucagon and insulin in therapy of fulminant hepatic failure. Gastroenterol. Jpn. 14: 453, 1979.
2. 2. Yazaki, Z., Kanai, F., Idezuki, Y., et al. The artificial liver - A mechanical liver support device. J. Clin. Exp. Med. 134: 809, 1985.
3. 3. Keller, G. A., West, M. A., Cerra, F. B., et al. Current research review: Macrophage-mediated modulation of hepatic function in multiple-system failure. J. Surg. Res. 39: 555, 1985.
4. 4. Oka, H. Current clinical topics (role of cyclic AMP in each disease): Liver disease. Saishin Igaku (Tokyo) 40: 345, 1985.
5. 5. Ignarro, L. J., Krassikoff, N., and Slywka, J. Release of enzymes from a rat liver lysosome fraction: Inhibition by catecholamines and cyclic 3′,5′-adenosine monophosphate, stimulation by cholinergic agents and cyclic 3′,5′-guanosine monophospate. J. Pharmacol. Exp. Ther. 186: 86, 1973.
6. 6. Ignarro, L. J., and Colombo, C. Enzyme release from polymorphonuclear leukocyte lysosomes: Regulation by autonomic drugs and cyclic nucleotides. Science 180: 1181, 1973.
7. 7. Sutherland, E. W., and Rall, T. W. Formation of a cyclic adenine ribonucleotide by tissue particles. J. Biol. Chem. 232: 1065, 1958.
8. 8. Sutherland, E. W. An introduction: Cyclic AMP and hormone action. In Robinson, G. A., Butcher, R. W., and Sutherland, E. W., (Eds.), Cyclic AMP. New York: Academic Press, 1971. P.1.
9. 9. Sutherland, E. W., Robinson, G. A., and Butcher, R. W. Some aspects of the biological role of adenosine 3′,5-monophosphate cyclic AMP. Circulation 37: 279, 1968.
10. 10. Kakisaka, A., Kasai, S., and Mito, M. Protective effects of DBcAMP on acute liver failure induced by D-galactosamine in rats. J. Jpn. Surg. Soc. 90: 396, 1989.
11. 11. Kakisaka, A., Kasai, S., Inagaki, M., et al. Protective effects of DBcAMP ischemic liver failure in dogs. Jpn. J. Gastroenterolo. 87: 1175, 1990.
12. 12. Noguchi, K., Matukuma, N., Yoshitake, M., et al. Galactosamine-induced liver damage. Kan Tan Sui (Tokyo) 19: 243, 1989.
13. 13. Kakisaka, A., Kasai, S., Kudo, K., Hoshi, T., and Mito, M. Protective effects of dibutyryl cyclic AMP and the role of the spleen on acute liver failure induced by D-galactosamine and lipopolysaccharide in rats. Acta Hepatol. Jpn. 33: 925, 1992.
14. 14. Arii, S., Sasaoka, T., Adachi, Y., et al. MOF and cytokines. Surg. Treat. 65: 165, 1991.
15. 15. Monden, K., Arii, S., et al. Enhancement of hepatic macrophages in septic rats and their inhibitory effect on hepatocyte function. J. Surg. Res. 50: 72, 1991.
16. 2 and some drugs on acute galactosamine induced liver damage in rat. Folia Histochem. Cytochem. 9: 311, 1980.
17. 2 on the liver and kidney. Prostaglandins 21: 97, 1981.
18. 18. Stachura, J., Tarnawski, A., Iver, K. J., Mach, T., Bogdal, J., Szczudrawa, J., and Klimczyk, B. Prostaglandin protection of carbon tetrachloride induced liver cell necrosis in tars. Gastroenterology 81: 211, 1981.
19. 2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J. Clin. Invest. 80: 881, 1987.
20. 2 on ischemia-induced hepatic cell injury. Transplantation 36: 238, 1983.
21. 2 in carbon tetrachloride induced acute hepatic injury in the rat. Prostaglandins 32: 439, 1986.
22. 4-induced damage. In Vitro Cell Dev. Biol. 8: 450, 1985.
23. 23. Ignarro, L. J. Regulation of lysosomal enzyme release by prostaglandins, autonomic neurohormones and cyclic nucleotides. Front. Biol. 43: 481, 1975.
24. 24. Robertson, R. P., Westcott, K. R., Storm, D. R., and Rice, M. G. Down regulation in vivo of PGE receptors and adenylate cyclase stimulation. Am. J. Physiol. 239: 75, 1980.
25. 25. Gorman, R. R., Bunting, S., and Miller, O. V. Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins 13: 377, 1977.
26. 26. Patorono, C., Rotella, C. M., Tocafondi, R. S., Aterini, S., Pinca, E., and Tanini, A. Prostacyclin stimulates the adenylate cyclase system of human thyroid tissue. Prostaglandins 22: 105, 1981.
27. 27. Wollin, A., Code, C. F., and Dousa, T. P. Interaction of prostaglandins and histamine with enzymes of cyclic AMP metabolism from guinea pig gastric mucosa. J. Clin. Invest. 57: 1548, 1976.